| Financial Services Industry | Financials Sector | Michael C. Boyd CEO | OTC PINK Exchange | 543137103 CUSIP |
| US Country | 8 Employees | 28 Jun 1999 Last Dividend | - Last Split | - IPO Date |
Longport, Inc. is a distinguished entity in the field of ultrasound imaging systems, with a primary market in the United States. The company showcases a profound specialization in developing, manufacturing, marketing, and selling high-resolution ultrasound imaging systems. These advanced systems play a crucial role in various medical and veterinary applications, offering indispensable tools for professionals in wound assessment, clinical dermatology, and more. Established in 1993 and rooted in Chadds Ford, Pennsylvania, Longport stands out for its innovative approach and dedication to enhancing diagnostic capabilities through ultrasound technology. It not only caters to the domestic market but also extends its reach globally through exports.
The EPISCAN I-200 represents a flagship product of Longport, Inc., utilizing ultrasound frequencies ranging between 20 and 50MHz. This high-frequency imaging system is ingeniously designed to offer unparalleled clarity and precision in imaging the skin and underlying soft tissues. Its application extends across multiple domains, underlining its versatility and reliability in various medical contexts.